Antibody Technologies Facility (MATF)

Equipment/facility: Facility


Monash Antibody Technologies Facility (MATF) is a global source of costeffective high quality, high affinity custom monoclonal antibodies. Our team of highly skilled scientists employ well-established standard operating procedures, along with the latest automated screening techniques, to deliver monoclonal antibodies in 20 weeks. Project deliverables are flexible and designed around the specific needs of our clients.